GlassScriptPhysician profile
Joseph L Dimenna
NPI 1205873155
$5,423.63
in general payments reported to CMS, 2019-2025
45 companies · $615 in 2025
The $615 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $350 · 2021: $681 · 2022: $904 · 2023: $631 · 2024: $1,673 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,255 · Travel and Lodging: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,255.10 |
| Travel and Lodging | $662.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,648.75 | 2019-2025 | Ortholoc 3di, Augment Injectable, Hoffmann |
| Organogenesis INC. | $741.67 | 2019-2024 | Puraply, Apligraf |
| Smith+Nephew, INC. | $442.09 | 2019-2025 | Stravix, Collagenase Santyl, Grafix Pl |
| Paratek Pharmaceuticals, INC. | $414.82 | 2020-2025 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $261.58 | 2019-2022 | |
| Eclipse Technology Solutions INC. | $148.16 | 2023-2025 | |
| Melinta Therapeutics, LLC | $130.87 | 2019-2021 | |
| Horizon Therapeutics Plc | $119.21 | 2020-2023 | Krystexxa |
| Bioventus LLC | $116.49 | 2019-2022 | |
| Grt US Holding, INC. | $83.53 | 2020-2022 | |
| Boston Scientific Corporation | $82.73 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Depuy Synthes Sales INC. | $81.02 | 2019-2022 | |
| Averitas Pharma INC. | $75.49 | 2023-2025 | Qutenza |
| Kerecis Limited | $68.32 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $67.77 | 2024-2025 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $66.17 | 2019 | |
| Amgen INC. | $59.68 | 2024-2025 | Krystexxa |
| Integra Lifesciences Corporation | $59.66 | 2020-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bsn Medical INC | $49.46 | 2022 | |
| Reprise Biomedical, INC. | $49.05 | 2025 | Miro3d |
| Bone Support INC. | $43.43 | 2025 | Ceramentbone Void Filler, Cerament G |
| Nabriva Therapeutics, Plc | $42.92 | 2020-2021 | |
| Orthofix Medical, INC. | $41.44 | 2023-2025 | Physio-Stim |
| Kci USA, INC. | $36.97 | 2021-2023 | Activ.A.C., Promogran Prisma |
| Zyla Life Sciences, INC. | $35.76 | 2019 | |
| Nevro Corp. | $35.30 | 2022-2023 | Senza |
| Inari Medical, INC. | $30.78 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.55 | 2019-2023 | Jublia |
| Medical Device Business Services, INC. | $30.23 | 2025 | Motoband |
| Alfasigma USA, INC. | $28.86 | 2020-2021 | |
| Next Science LLC | $25.25 | 2023 | Surgx, Blastx, Xperience |
| Journey Medical Corporation | $24.94 | 2019-2020 | |
| Abbott Laboratories | $24.78 | 2023 | Proclaim |
| Solventum Corporation | $24.19 | 2024 | Activ.A.C., Promogran Prisma |
| Medtronic, INC. | $22.33 | 2022 | |
| Anika Therapeutics, INC. | $21.74 | 2022 | |
| Paragon 28, INC. | $21.55 | 2023 | Precision Guide Lapidus |
| Wright Medical Technology, INC. | $21.21 | 2020 | |
| Biotissue Holdings INC. | $20.32 | 2021 | |
| Tactile Systems Technology INC | $19.76 | 2025 | Nimbl, Flexitouch Plus |
| Linvatec Corporation | $17.13 | 2020 | |
| Convatec INC. | $17.11 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $15.86 | 2023 | Iovera, Exparel |
| Heron Therapeutics, INC. | $13.08 | 2022 | |
| Merck Sharp & Dohme LLC | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Dimenna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.